WebApr 21, 2015 · The biological protein ACTIMMUNE has been shown to be effective in decreasing the frequency and severity of serious infections and has already been approved by the FDA to treat both the genetic conditions Chronic Granulomatous Disease (CGD) and malignant osteoporosis (SMO). WebActimmune (Interferon gamma-1b) was developed by Horizon Pharma as a potential treatment for cancer. It is a recombinant protein, similar to a protein produced by the immune system called interferon-gamma (IFN-gamma). The U.S. Food and Drug Administration (FDA) has already approved Actimmune to treat two rare diseases, …
Actimmune: Drug Basics and Frequently Asked Questions - GoodRx
WebApr 17, 2024 · FDA approved Actimmune for the treatment of chronic granulomatous disease and severe, malignant osteopetrosis. The government alleged that InterMune promoted Actimmune for the treatment of idiopathic pulmonary fibrosis (IPF), a condition for which the company had not received FDA approval. WebSep 21, 2024 · Actimmune is a prescription medicine used to treat the symptoms of Chronic Granulomatous Disease and Malignant Osteopetrosis. Actimmune may be used alone or with other medications. Actimmune belongs to a class of drugs called Biological Response Modifiers. It is not known if Actimmune is safe and effective in children. new island seafood menu
The drug company that prospered without creating any drugs
WebACTIMMUNE ® (Interferon gamma-1b) was approved by the FDA in 1990 after a study was conducted with 128 people who had chronic granulomatous disease (CGD). The most … WebACTIMMUNE (Interferon gamma-1b) for CGD - An HCP Resource For US Healthcare Professionals TOMORROW’S INFECTION CAN BE PREVENTED TODAY Provide protection with ACTIMMUNE ® (Interferon gamma-1b), the only FDA-approved biologic therapy indicated for reducing the frequency and severity of serious infections* … WebThe FDA-approved product labeling can be found at http://www.ACTIMMUNE.com or 1-866-479-6742. Important Safety Information What is ACTIMMUNE ® (Interferon gamma … in the space of just a few years